followed by DIBALH reduction. Sharpless oxidation of 17
assisted by (ꢀ)-diethy-D-tartrate (D-DET) provided diaster-
eomerically pure anti(R)-epoxide 18, which was oxidized by
using Dess-Martin periodinane (DMP) to afford aldehyde 19.
C1-extension of 19 by the Colvin/Shioiri protocol13 gave the
epoxyalkyne 20 similarly as described for closely related
substrates.5c,14 By using Pd(PPh3)4 and CuI as catalysts in
diisopropylamine and by degassing the reaction mixture,
Sonogashira cross-coupling between 20 and vinyl iodide
2111b gave the desired epoxyalcohol 22 in high yield. The
stereospecific SN20 hydride reduction of 22 with DIBALH
produced the known allenic diol 23,15 which was converted to
tri-n-butylphosphonium salt 7 via the corresponding allylic
chloride. The total yield of the phosphonium salt 7 from
(ꢀ)-actinol (13) was 34% over 11 steps.
provided the desired saturated ester 28 in 54% yield,
accompanied by some products of oxirane ring opening.16
Ester 28 was transformed into the C1-shortened aldehyde 9
in three steps. Treatment of 28 with commercially available
oxaziridine 2917 in the presence of LDA yielded R-hydro-
xylated 30 as a single diastereomer; this was reduced with
LAH, and the resulting glycol was cleaved with NaIO4 to
afford aldehyde 9 in high yield. The total yield of 9 from
(ꢀ)-actinol (13) was 30% over 11 steps.
C11-Epoxyaldehyde 9 was then converted into C25-
apocarotenal 6 as shown in Scheme 4. Aldehyde 9 was
treated with a reagent obtained from alkenyl bromide
319,18 and t-BuLi to give the diastereomeric alcohols 32
as an unassigned 2:1 mixture; without separating the
diastereomers, 32 was acetylated and then desilylated to
yield diol 33. MnO2 oxidation of 33 and protection of the
C3-hydroxyl with TES afforded aldehyde 34. The C8-
acetoxy group on compound 34 is ultimately transformed
into a carbonyl group, which destroys the stereogenic
center and makes the separation of the diastereomers
unnecessary. However, we separated the diastereomers in
this step for the sake of convenience in spectral analyses of
subsequent compounds. The major diastereomer of 34 was
condensed with the previously reported10 C10-phospho-
nate 11, and the resulting pentaenoate was subjected to
LAH reduction followed by MnO2 oxidation and subse-
quent deprotection to provide all-E-apocarotenal 6 and its
13Z-isomer in 50% and 19% yield from 34, respectively.
The 13Z-isomer was converted into the desired all-E-
isomer (73%: HPLC yield) by isomerization19 using a
palladium catalyst. The minor diastereomer of 34 was also
converted into the corresponding apocarotenal.
Scheme 3. Synthesis of C11-Epoxyaldehyde 9
Scheme 4. Synthesis of C25-Apocarotenal 6
Next, C11-epoxyaldehyde 9, the precursor of apocarote-
nal 6, was prepared as shown in Scheme 3. Previously
reported9 epoxyacetate 25a was easily converted into
epoxyaldehyde 9 by LAH reduction followed by DMP
oxidation, but the overall yield of 9 from 13 was as low as
19%, mainly due to the poor diastereoselectivity of epox-
idizing alkene 24. Thus, weinvestigatedthe transformation
of C10-epoxyalcohol 12, which has been prepared11 in a
highly stereoselective manner, into C11-compound 9. Be-
cause several trials of the direct C1-extension using alcohol
12 and corresponding aldehyde 26 were unsuccessful,
aldehyde 26 was converted into a C2-elongated conjugated
ester 27 by the HornerꢀEmmons reaction. After a detailed
investigation of reduction reagents and catalysts, it was
found that hydrogenation of 27 by using Pd/C as a catalyst
The next step toward amarouciaxanthin A and B was
Wittig condensation of C25-apocarotenal 6 with C15-tri-n-
butylphosphonium salts 7and 8(Scheme5). Weinvestigated
the further transformation by using the major diastereomer
(16) The data of oxirane ring opening products are provided in the
Supporting Information.
(11) (a) Furuichi, N.; Hara, H.; Osaki, T.; Mori, H.; Katsumura, S.
Angew. Chem., Int. Ed. 2002, 41, 1023. (b) Furuichi, N.; Hara, H.; Osaki,
T.; Nakano, M.; Mori, H.; Katsumura, S. J. Org. Chem. 2004, 69, 7949.
(12) Stille, J. K.; Wong, P. K. J. Org. Chem. 1975, 40, 532.
(17) Davis, F. A.; Reddy, G. V.; Chen, B.-C.; Kumar, A.; Haque,
M. S. J. Org. Chem. 1995, 60, 6148.
ꢀ
(18) de Lera, A. R.; Iglesias, B.; Rodriguez, J.; Alvarez, R.; Lopez, S.;
ꢀ
Villanueva, X.; Padros, E. J. Am. Chem. Soc. 1995, 117, 8220.
(13) Miwa, K.; Aoyama, T.; Shioiri, T. Synlett 1994, 107.
(19) (a) Fischli, A.; Mayer, H.; Simon, W.; Stoller, H.-J. Helv. Chim.
Acta 1976, 59, 397. (b) Yamano, Y.; Ito, M. Org. Biomol. Chem. 2007, 5,
3207.
€
(14) Olpp, T.; Bruckner, R. Angew. Chem., Int. Ed. 2006, 45, 4023.
(15) Baumeler, A.; Eugster, C. H. Helv. Chim. Acta 1991, 74, 469.
5312
Org. Lett., Vol. 15, No. 20, 2013